Syneron to Participate in Three Upcoming Investor Conferences

Syneron to Participate in Three Upcoming Investor Conferences:

Brean Murray, Carret & Co. Life Sciences Summit
Date: Monday, November 14, 2011
Syneron Participant: Asaf Alperovitz, Chief Financial Officer

Conference: Lazard Capital Markets 8th Annual Healthcare Conference
Date and Time: 2:30 pm ET on Wednesday, November 16, 2011
Syneron Participant: Asaf Alperovitz, Chief Financial Officer

Conference: Leerink Swann Healthcare Management Access Day
Date: Monday, November 21, 2011
Syneron Participant: Louis P. Scafuri, Chief Executive Officer 

 

Read More

See more in:

Syneron® manufactures and sells ablative and non-ablative medical aesthetic devices that use the patented elos technology with applications for treatment of wrinkles, skin, age spots, cellulite, acne, rosacea, hair removal, leg veins, spider veins, and much more.  elos technology combines radio frequency and light energies, and is sold to dermatologists, plastic surgeons, family practitioners and other physicians, aestheticians, and medical spa professionals around the world.